Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Oligomannate for Prevention of Post-stroke Cognitive Impairment
NCT05545605Recruiting
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Apr 2023
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of sodium oligomannate in post-stroke cognitive impairment (PSCI) (2 arms), sponsored by Nanfang Hospital, Southern Medical University. Primary endpoint: Incidence of Post-stroke Cognitive Impairment at 6 months. Started Apr 2023; status: recruiting.
02
Drugs
sodium oligomannate
03
Conditions
post-stroke cognitive impairment (PSCI)
Beyond the preview
Go deeper on NCT05545605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05545605.